Emergent Biosolutions(EBS-N)NYSE
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Latest News
Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript
Motley Fool - Thu Nov 7, 12:15AM CST
Motley Fool
Thu Nov 7, 12:15AM CST
EBS earnings call for the period ending September 30, 2024.
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa
GlobeNewswire - Wed Nov 6, 3:49PM CST
GlobeNewswire
Wed Nov 6, 3:49PM CST
Emergent BioSolutions Reports Third Quarter 2024 Financial Results
GlobeNewswire - Wed Nov 6, 3:05PM CST
GlobeNewswire
Wed Nov 6, 3:05PM CST
Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development
GlobeNewswire - Mon Nov 4, 6:30AM CST
GlobeNewswire
Mon Nov 4, 6:30AM CST
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024
GlobeNewswire - Wed Oct 23, 6:30AM CDT
GlobeNewswire
Wed Oct 23, 6:30AM CDT
Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic
GlobeNewswire - Tue Oct 8, 4:32PM CDT
GlobeNewswire
Tue Oct 8, 4:32PM CDT
Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility
GlobeNewswire - Wed Oct 2, 6:30AM CDT
GlobeNewswire
Wed Oct 2, 6:30AM CDT
Why Emergent BioSolutions Stock Is Skyrocketing Today
Motley Fool - Fri Aug 16, 11:51AM CDT
Motley Fool
Fri Aug 16, 11:51AM CDT
Concerns about the mpox outbreak are causing Emergent BioSolutions' shares to jump.
Emergent BioSolutions (EBS) Q2 2024 Earnings Call Transcript
Motley Fool - Wed Aug 7, 1:45AM CDT
Motley Fool
Wed Aug 7, 1:45AM CDT
EBS earnings call for the period ending June 30, 2024.
Emergent BioSolutions Announces Shelf-Life Extension for NARCAN® Nasal Spray in Canada
GlobeNewswire - Mon Jul 22, 7:00AM CDT
GlobeNewswire
Mon Jul 22, 7:00AM CDT
Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
Motley Fool - Wed May 1, 10:45PM CDT
Motley Fool
Wed May 1, 10:45PM CDT
EBS earnings call for the period ending March 31, 2024.
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript
Motley Fool - Wed Mar 6, 10:30PM CST
Motley Fool
Wed Mar 6, 10:30PM CST
EBS earnings call for the period ending December 31, 2023.
Emergent BioSolutions (EBS) Q3 2023 Earnings Call Transcript
Motley Fool - Wed Nov 8, 2023
Motley Fool
Wed Nov 8, 2023
EBS earnings call for the period ending September 30, 2023.
Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic
PR Newswire - Mon Oct 16, 2023
PR Newswire
Mon Oct 16, 2023
/PRNewswire/ -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced it is teaming up with football icon, Emmitt Smith, to break down the stigma around...
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
GlobeNewswire - Mon Oct 2, 2023
GlobeNewswire
Mon Oct 2, 2023
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
GlobeNewswire - Wed Aug 30, 2023
GlobeNewswire
Wed Aug 30, 2023
Why Emergent BioSolutions Stock Is Tumbling Today
Motley Fool - Tue Aug 22, 2023
Motley Fool
Tue Aug 22, 2023
The healthcare stock will soon be booted from an index tracked by several ETFs.
Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600
PR Newswire - Mon Aug 21, 2023
PR Newswire
Mon Aug 21, 2023
/PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) will replace Advance Auto Parts Inc. (NYSE: AAP) in the S&P 500, and Advance Auto Parts will replace Emergent...
Emergent BioSolutions (EBS) Q2 2023 Earnings Call Transcript
Motley Fool - Tue Aug 8, 2023
Motley Fool
Tue Aug 8, 2023
EBS earnings call for the period ending June 30, 2023.
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Emergent BioSolutions Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
PR Newswire - Tue Aug 8, 2023
PR Newswire
Tue Aug 8, 2023
/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...
Why Emergent BioSolutions Stock Dived by 9% Today
Motley Fool - Tue Jun 27, 2023
Motley Fool
Tue Jun 27, 2023
Investors didn't greet news of the CEO's departure warmly.
Better Recovery-Story Buy: Emergent BioSolutions or Invitae?
Motley Fool - Mon Jun 26, 2023
Motley Fool
Mon Jun 26, 2023
Both of these stocks have plummeted more than 50% over the past year.
Is Emergent BioSolutions Stock a Buy Now?
Motley Fool - Fri Jun 9, 2023
Motley Fool
Fri Jun 9, 2023
The deluge of bad news seems to be over, and a recovery could be in the works.
Down 75%, Can Emergent BioSolutions Turn Things Around?
Motley Fool - Wed Jun 7, 2023
Motley Fool
Wed Jun 7, 2023
Has the stock finally bottomed out?
Why Emergent BioSolutions Stock Inched Slightly Higher Today
Motley Fool - Mon May 15, 2023
Motley Fool
Mon May 15, 2023
Investors approved, if not enthusiastically, their company's latest asset sale.